Blackey Brent G 4

4 · Cardiovascular Systems Inc · Filed Sep 5, 2018

Form 4

Period: 2018-09-01

Director

Transactions

Exercise/Conversion
Common Stock
2018-09-01+2,855→ 97,196 total
Exercise/Conversion
Restricted Stock Units
2018-09-01−2,855→ 0 total
From: 2018-09-01Exp: 2018-09-01→ Common Stock (2,855 underlying)

Holdings

Restricted Stock Units
→ Common Stock (3,527 underlying)
3,527
Restricted Stock Units
From: 2019-09-01Exp: 2019-09-01→ Common Stock (2,095 underlying)
2,095
Restricted Stock Units
→ Common Stock (81,302 underlying)
81,302
Restricted Stock Units
From: 2019-08-15Exp: 2019-08-15→ Common Stock (2,541 underlying)
2,541

Footnotes (4)

[F1]Restricted stock units were paid in shares of common stock on a one-for-one basis.
[F2]Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.
[F3]Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning on the payment date.
[F4]Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 882 shares on each of September 30, 2018, December 31, 2018 and March 31, 2019 and 881 shares on June 30, 2019.

Documents

1 file